FDA clears Sectras full-field digital mammo system

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Screening mammography with breast tomosynthesis in a 57-year-old woman. Image source: RadioGraphics
The FDA has granted approval for the 510(k) application by Sectra Medical Systems to sell the Sectra MicroDose L30 full-field digital mammography (FFDM) unit in the U.S.

The Linköping, Sweden-based company said its Sectra MicroDose Mammography L30 is a flat-panel FFDM system with scanning multislit geometry and a 24 x 26-cm field-of-view, as well as photon-counting technology.

Until accreditation is available from their accreditation bodies, mammography facilities that want to use this unit under their existing Mammography Quality Standards Act (MQSA) certificate must apply to the FDA’s Certification Extension Program.

 

Justine Varieur Cadet

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.